BTIG Research Cuts OrthoPediatrics (NASDAQ:KIDS) Price Target to $39.00

Key Points

• BTIG Research has reduced the price target for OrthoPediatrics (NASDAQ:KIDS) from $40.00 to $39.00, while maintaining a "buy" rating, indicating a potential upside of 121.15% from the stock's previous close.
• OrthoPediatrics shares have experienced a significant drop of 12.7% during trading, closing at $17.64, compared to a 12-month high of $33.14.
• Currently, equities analysts show a mixed outlook on the stock, with one "sell," one "hold," and six "buy" ratings, leading to an average rating of "Moderate Buy".

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) had its price target lowered by research analysts at BTIG Research from $40.00 to $39.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. BTIG Research's target price suggests a potential upside of 121.15% from the stock's previous close.

Other equities research analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a research report on Friday, July 18th. Truist Financial lowered their price target on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Piper Sandler decreased their target price on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research report on Thursday, May 8th. Finally, Needham & Company LLC reissued a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $36.29.

OrthoPediatrics Trading Down 12.7%

KIDS stock traded down $2.56 during mid-day trading on Wednesday, reaching $17.64. The company had a trading volume of 213,551 shares, compared to its average volume of 200,287. The company has a debt-to-equity ratio of 0.21, a current ratio of 6.19 and a quick ratio of 2.99. The company has a market capitalization of $428.35 million, a PE ratio of -10.13 and a beta of 1.12. The firm has a 50 day moving average of $21.48 and a 200 day moving average of $22.79. OrthoPediatrics has a 12 month low of $16.59 and a 12 month high of $33.14.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.13). OrthoPediatrics had a negative return on equity of 7.03% and a negative net margin of 19.15%. The business had revenue of $52.41 million during the quarter, compared to analysts' expectations of $51.68 million. On average, equities analysts predict that OrthoPediatrics will post -0.93 earnings per share for the current fiscal year.

Institutional Trading of OrthoPediatrics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. KLP Kapitalforvaltning AS purchased a new position in OrthoPediatrics during the fourth quarter valued at $79,000. Wells Fargo & Company MN lifted its holdings in OrthoPediatrics by 31.1% during the fourth quarter. Wells Fargo & Company MN now owns 9,853 shares of the company's stock valued at $228,000 after purchasing an additional 2,338 shares in the last quarter. PDT Partners LLC purchased a new position in OrthoPediatrics during the first quarter valued at $244,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in OrthoPediatrics by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after purchasing an additional 645 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of OrthoPediatrics by 4,618.2% in the first quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock worth $261,000 after buying an additional 10,391 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.